Zhejiang Hisun Pharmaceutical Co., Ltd. (SHA:600267)
China · Delayed Price · Currency is CNY 13.40
-0.43 (-3.11%)
Nov 6, 2026, 3:00 PM CST
SHA:600267 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 9,148 | 10,550 | 10,340 | 10,373 | 12,037 | 12,136 |
Revenue Growth | -11.95% | 2.02% | -0.32% | -13.82% | -0.82% | 6.89% |
Gross Profit Gross Profit Growth | 4,856 | 4,612 | 4,154 | 4,035 | 4,918 | 4,806 |
Operating Income Operating Income Growth | 1,483 | 1,085 | 657.14 | 316.55 | 956.29 | 855.41 |
Net Income Net Income Growth | 1,225 | 540.71 | 601.18 | -93.17 | 488.86 | 486.89 |
Earnings Per Share EPS Growth | 1.04 | 0.46 | 0.52 | -0.08 | 0.42 | 0.43 |
EPS Growth | 117.05% | -11.54% | - | - | -2.33% | 0% |
Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Pharmaceutical Manufacturing Pharmaceutical Manufacturing Growth | 6,497 |
Pharmaceutical Business Pharmaceutical Business Growth | 3,897 |
CMO/CDMO/CRO Business CMO/CDMO/CRO Business Growth | 7.8 |
Others Others Growth | 18.93 |
Total Total Growth | 10,421 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,177 | 1,295 | 1,498 | 1,587 | 1,399 | 1,299 |
Total Debt Total Debt Growth | 1,547 | 2,940 | 4,150 | 5,613 | 6,419 | 7,855 |
Net Cash (Debt) Net Cash Growth | -369.35 | -1,645 | -2,652 | -4,026 | -5,020 | -6,556 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.31 | -1.40 | -2.29 | -3.46 | -4.31 | -5.79 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,593 | 2,032 | 2,184 | 1,503 | 2,066 | 1,737 |
Capital Expenditures CapEx Growth | -503.35 | -376.4 | -238.44 | -240.04 | -530.62 | -622.38 |
Free Cash Flow Free Cash Flow Growth | 1,089 | 1,655 | 1,946 | 1,263 | 1,535 | 1,114 |
Free Cash Flow Growth | -46.50% | -14.92% | 54.10% | -17.75% | 37.78% | 24.13% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 53.09% | 43.71% | 40.17% | 38.90% | 40.86% | 39.60% |
Operating Margin | 16.21% | 10.28% | 6.35% | 3.05% | 7.95% | 7.05% |
Pretax Margin | 17.43% | 7.73% | 6.94% | -0.80% | 5.68% | 5.31% |
Profit Margin | 13.40% | 5.13% | 5.81% | -0.90% | 4.06% | 4.01% |
FCF Margin | 11.91% | 15.69% | 18.82% | 12.17% | 12.75% | 9.18% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.210 | 0.210 | 0.210 | - | 0.170 | 0.140 |
Dividend Per Share Growth | 0% | 0% | - | - | 21.43% | 182.26% |
Dividend Yield | 1.57% | 2.12% | 2.53% | - | 1.54% | 1.00% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 12.89 | 21.28 | 16.14 | - | 26.46 | 34.37 |
Forward PE | 31.16 | 23.27 | 207.50 | 156.00 | 160.67 | 160.67 |
P/FCF Ratio | 14.25 | 6.95 | 4.99 | 8.82 | 8.43 | 15.02 |
PS Ratio | 1.70 | 1.09 | 0.94 | 1.07 | 1.08 | 1.38 |